Epigral · NSE: EPIGRAL · BSE: 543332

Q3 FY22 results · Oct–Dec 2021

Epigral reported revenue from operations of ₹422.17 crore and net profit of ₹69.73 crore for Q3 FY22 (Oct–Dec 2021), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY22Q3 FY21YoYQ2 FY22QoQ
Revenue from operations422.17——339.63+24.3%
Other income(0.30)——2.26Turned loss
Total income421.88——341.89+23.4%
Profit before tax108.90——71.34+52.6%
Net profit for the period69.73——47.01+48.3%
EPS, basic (₹)16.78——11.31+48.4%
Net margin (%)16.5—13.8
Standalone · ₹ crore
ItemQ3 FY22Q3 FY21YoYQ2 FY22QoQ
Revenue from operations422.17——339.63+24.3%
Other income(0.30)——2.26Turned loss
Total income421.88——341.89+23.4%
Profit before tax108.90——71.34+52.6%
Net profit for the period69.73——47.01+48.3%
EPS, basic (₹)16.78——11.31+48.4%
Net margin (%)16.5—13.8
Consolidated
Filed with BSE
24 Jan 2022, 18:02 IST
Board meeting
24 Jan 2022
Period
01 Oct 2021 to 31 Dec 2021
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
24 Jan 2022, 18:02 IST
Board meeting
24 Jan 2022
Period
01 Oct 2021 to 31 Dec 2021
Review status
Unaudited
Source
XBRL filing on BSE